nach oben

Breast Cancer Research

Erschienen in:

01.05.2008 | Poster presentation

Exploring the breast cancer experiences, needs and preferences of women aged 70 years and over: a study in progress

verfasst von: J Moffat, C Foster, D Fenlon, J Addington-Hall

Erschienen in: Breast Cancer Research | Sonderheft 2/2008

Einloggen, um Zugang zu erhalten

Excerpt

Tens of thousands of women are diagnosed with breast cancer each year in the UK. Because the risk of developing the disease increases with age, more than one-third of cases are diagnosed in women aged 70 years and over. In addition, improvements in treatment have meant that many women, diagnosed before the age of 70, are surviving into older age. Despite this, the breast cancer experiences of women in the age group of 70 years plus have been largely neglected [1], alongside their information and support needs and preferences. So whilst it is recognised that women in this age group are less likely to use existing information and support opportunities [2], it is not known why this is so. …

Ballantyne PJ: Social context and outcomes for the ageing breast cancer patient: considerations for clinical practitioners. J Clin Nurs. 2004, 13: 11-21. 10.1111/j.1365-2702.2004.00921.x.CrossRefPubMed

Mills ME, Davidson R: Cancer patients' sources of information: use and quality issues. Psycho-Oncology. 2002, 11: 371-378. 10.1002/pon.584.CrossRefPubMed

Titel: Exploring the breast cancer experiences, needs and preferences of women aged 70 years and over: a study in progress
verfasst von: J Moffat
C Foster
D Fenlon
J Addington-Hall
Publikationsdatum: 01.05.2008
Verlag: BioMed Central
Erschienen in: Breast Cancer Research / Ausgabe Sonderheft 2/2008
Elektronische ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr1969

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Exploring the breast cancer experiences, needs and preferences of women aged 70 years and over: a study in progress

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Sonderheft 2/2008

Investigating h-Prune activation of Wnt signalling in breast cancer

Inhibition of apoptosis by Notch signalling in breast epithelial cells

Activation of TGF-beta signalling in breast cancer metastatic cells

Modelling estrogen receptor alpha-positive breast cancer by transformation of normal human mammary epithelial cells

Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie